Cardiology News

Get updates on cardiology with press releases highlighting research, treatments, and innovations advancing heart health and cardiovascular medicine. Explore developments influencing cardiology and opportunities in medical advancements and heart disease prevention.

Mar 18, 2026 at 11:59 AM

Eurosets Launches U.S. Commercialization of Trilly and Horizon Following FDA Clearance and Enters Strategic Partnership with Orion Medical

MEDOLLA, Italy & PLYMOUTH, Mich.--(BUSINESS WIRE)--Eurosets is pleased to announce the official start of U.S. commercialization for the Trilly and Horizon oxygenators, following successful FDA 510(k) clearance. This milestone reflects our commitment to supporting clinicians with reliable, high-performance technologies at a time when the U.S. healthcare system continues to face a critical and growing need for oxygenators and life-support solutions. Equipped with an integrated stainless-steel hea...
Mar 18, 2026 at 8:00 AM

Kain Capital Expands Investment and Strategy Leadership with Hiring of Sameer Mathur as Partner and Bridie Gahan as Vice President of Strategy

NEW YORK--(BUSINESS WIRE)--Kain Capital LLC (“Kain”), a private equity firm focused on the technology enablement of healthcare services companies, today announced the appointments of Sameer Mathur as Partner and Bridie Gahan as Vice President of Strategy. The additions further strengthen Kain’s investment and operational leadership as the firm continues to expand its healthcare investment platform. Sameer Mathur joins Kain with more than 16 years of principal investing experience across healthc...
Mar 18, 2026 at 3:00 AM

Truffle Capital Unveils the First Edition of the Truffle MedTech 10

PARIS--(BUSINESS WIRE)--Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. This is the first ranking of the top ten publicly traded companies by market capitalization in the pre-commercial and early commercial interventional MedTech sector. Using PitchBook (https://pitchbook.com) data as of March 12th, 2026, this list identifies companies developing me...
Mar 17, 2026 at 10:00 AM

Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced new real-world evidence (RWE) demonstrating improved time in range (TIR) through the use of Welldoc’s Continuous Glucose Monitor (CGM)-informed insulin bolus calculator. For the millions of people who use bolus insulin, daily management is a burden. People with insulin-dependent diabetes make numerous, complex health-related decisions every day. When calculating a mealtime dose, in...
Mar 17, 2026 at 9:00 AM

Kardigan Announces Multiple Presentations at ACC.26 from its Late-Stage Portfolio of Personalized Cardiovascular Medicines

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan announced today that it will have multiple presentations at ACC.26, taking place on March 28-30, 2026, in New Orleans....
Mar 17, 2026 at 7:00 AM

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and accelerate the development and future commercialization of its nPulse Cardiac Catheter Ablation System. “The European feasibility data from over 150 patients sends a definitive message,” said Bob Duggan, Co-Chairman of Pulse Biosciences. “The nPulse clinical perform...
Mar 17, 2026 at 7:00 AM

Sensome Announces Successful Proof‑of‑Concept Adding Its Biological Intelligence to Robotic Thrombectomy

PARIS--(BUSINESS WIRE)--Sensome announces successful proof-of-concept cases using its Clotild Smart Guidewire System in robotic thrombectomy, showing a path to Physical AI....
Mar 16, 2026 at 11:00 AM

Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch

LIMA, Peru--(BUSINESS WIRE)--Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a significant advance in the approach to cardiac arrhythmias, with benefits in terms of safety, precision, and procedural efficiency.1 "With this launch, Peru joins the Latin American countries that already have this world-class innovation, used in international referenc...
Mar 16, 2026 at 9:00 AM

OpenEvidence and AAO-HNSF Pioneer a New Model for Updating Clinical Practice Guidelines

ALEXANDRIA, Va. & MIAMI--(BUSINESS WIRE)--AAO-HNSF and OpenEvidence use AI to update clinical practice guidelines and align standards of care with the latest clinical evidence as it evolves....
Mar 16, 2026 at 8:00 AM

Eccogene Announces First Patient Enrolled in MIST Phase 2a Trial Evaluating ECC4703 as an Adjunct to Semaglutide for the Treatment of Obesity

BOSTON & SHANGHAI--(BUSINESS WIRE)--Eccogene Announces First Patient Enrolled in MIST Phase 2a Trial Evaluating ECC4703 as an Adjunct to Semaglutide for the Treatment of Obesity...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up